CKM and metabolic dysfunction-associated steatotic liver disease: Among individuals with NAFLD, age-standardized all-cause mortality increased progressively with CKM severity, ranging from 23.0 % in Stage 0 to 34.1 % in Stage 2, peaking at 58.6 % in advanced CKM.